Robert Cavaliere

1.6k total citations
53 papers, 1.1k citations indexed

About

Robert Cavaliere is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Cavaliere has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 19 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Cavaliere's work include Glioma Diagnosis and Treatment (31 papers), Brain Metastases and Treatment (14 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Robert Cavaliere is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Brain Metastases and Treatment (14 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Robert Cavaliere collaborates with scholars based in United States, Belgium and India. Robert Cavaliere's co-authors include David Schiff, Maria Beatriz Lopes, Gina R. Petroni, Simon S. Lo, Herbert B. Newton, J.C. Grecula, Susan D. Bell, Todd Trask, Andrea G. Manzanera and E. Antonio Chiocca and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Robert Cavaliere

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Cavaliere United States 17 529 430 274 247 196 53 1.1k
Paolo Nozza Italy 21 512 1.0× 187 0.4× 273 1.0× 337 1.4× 215 1.1× 93 1.3k
Philipp Karschnia Germany 18 414 0.8× 454 1.1× 215 0.8× 169 0.7× 164 0.8× 81 1.1k
Sonia Tejada Spain 15 822 1.6× 442 1.0× 228 0.8× 185 0.7× 112 0.6× 34 1.2k
Ricardo Díez-Valle Spain 15 706 1.3× 432 1.0× 196 0.7× 333 1.3× 88 0.4× 27 1.2k
Masahide Matsuda Japan 21 622 1.2× 228 0.5× 235 0.9× 218 0.9× 234 1.2× 110 1.3k
Nicholas A. Vitanza United States 16 590 1.1× 319 0.7× 137 0.5× 443 1.8× 236 1.2× 63 1.1k
Abderrahmane Hamlat France 22 572 1.1× 271 0.6× 196 0.7× 486 2.0× 260 1.3× 63 1.6k
Ulf Nestler Germany 19 585 1.1× 186 0.4× 329 1.2× 414 1.7× 333 1.7× 80 1.5k
Ali Chahlavi United States 14 190 0.4× 257 0.6× 212 0.8× 253 1.0× 177 0.9× 21 872
Jaime Gállego Pérez‐Larraya Spain 18 861 1.6× 536 1.2× 409 1.5× 354 1.4× 136 0.7× 48 1.5k

Countries citing papers authored by Robert Cavaliere

Since Specialization
Citations

This map shows the geographic impact of Robert Cavaliere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Cavaliere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Cavaliere more than expected).

Fields of papers citing papers by Robert Cavaliere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Cavaliere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Cavaliere. The network helps show where Robert Cavaliere may publish in the future.

Co-authorship network of co-authors of Robert Cavaliere

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Cavaliere. A scholar is included among the top collaborators of Robert Cavaliere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Cavaliere. Robert Cavaliere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiff, David, Anne O’Neill, Paul D. Brown, et al.. (2024). LTBK-07. PROGRESSION-FREE AND OVERALL SURVIVAL RESULTS OF ECOG-ACRIN E3F05: A PHASE 3 INTERGROUP TRIAL OF RADIATION ± TEMOZOLOMIDE FOR GRADE II GLIOMAS. Neuro-Oncology. 26(Supplement_8). viii1–viii2. 4 indexed citations
2.
Collier, Katharine A., Herbert B. Newton, Erinn M. Hade, et al.. (2021). A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. Cancer Chemotherapy and Pharmacology. 87(5). 599–611. 20 indexed citations
3.
Holtzman, Adam L., Ronny L. Rotondo, Daniel J. Indelicato, et al.. (2021). Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes. Journal of Neuro-Oncology. 153(3). 467–476. 8 indexed citations
4.
Ng, Alan, et al.. (2021). Biologics in the Treatment of Plantar Fasciitis. Clinics in Podiatric Medicine and Surgery. 38(2). 245–259. 2 indexed citations
5.
Holtzman, Adam L., Ronny L. Rotondo, Daniel J. Indelicato, et al.. (2021). Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes. Journal of Neuro-Oncology. 153(3). 477–477. 1 indexed citations
6.
Wang, Joshua, Rolf F. Barth, Robert Cavaliere, et al.. (2020). Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS ONE. 15(12). e0244383–e0244383. 20 indexed citations
7.
Haverkos, Bradley M., Ludmila Katherine Martin, Mark Lustberg, et al.. (2018). Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone. Clinical Cancer Research. 24(14). 3273–3281. 16 indexed citations
8.
Robins, H. Ian, Peixin Zhang, Mark R. Gilbert, et al.. (2015). A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study. Journal of Neuro-Oncology. 126(2). 309–316. 58 indexed citations
9.
Mrugała, Maciej M., Herbert H. Engelhard, David Tran, et al.. (2014). Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe). Seminars in Oncology. 41. S4–S13. 119 indexed citations
10.
Hafeez, Shaheryar & Robert Cavaliere. (2012). Recent Innovations in the Management of Low-Grade Gliomas. Current Treatment Options in Neurology. 14(4). 369–380. 1 indexed citations
11.
Goldlust, Samuel, Robert Cavaliere, Herbert B. Newton, et al.. (2011). Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors. Journal of Neuro-Oncology. 107(2). 407–411. 13 indexed citations
12.
Dierickx, Daan, et al.. (2010). Primary Central Nervous System Post-Transplatation Lymphoproliferative Disorder. Cancer. 116(14). 3521–3522. 1 indexed citations
13.
Shiue, Kevin, Arjun Sahgal, Edward Chow, et al.. (2010). Management of metastatic spinal cord compression. Expert Review of Anticancer Therapy. 10(5). 697–708. 24 indexed citations
14.
Lo, Simon S., James W. Clarke, J.C. Grecula, et al.. (2010). Stereotactic radiosurgery alone for patients with 1–4 radioresistant brain metastases. Medical Oncology. 28(S1). 439–444. 19 indexed citations
15.
Clarke, James W., Eric L. Chang, Victor A. Levin, et al.. (2008). Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients. Expert Review of Anticancer Therapy. 8(5). 733–741. 11 indexed citations
16.
Hadziahmetovic, Mersiha, et al.. (2007). Palliative treatment of poor prognosis patients with malignant gliomas. Expert Review of Anticancer Therapy. 8(1). 125–132. 2 indexed citations
17.
Cavaliere, Robert, Elana Farace, & David Schiff. (2006). Clinical Implications of Status Epilepticus in Patients With Neoplasms. Archives of Neurology. 63(12). 1746–1746. 40 indexed citations
18.
Cavaliere, Robert & David Schiff. (2006). Cerebral metastases—a therapeutic update. Nature Clinical Practice Neurology. 2(8). 426–436. 10 indexed citations
19.
Newton, Herbert B., Abhik Ray‐Chaudhury, & Robert Cavaliere. (2006). Brain Tumor Imaging and Cancer Management. Topics in Magnetic Resonance Imaging. 17(2). 127–136. 9 indexed citations
20.
Cavaliere, Robert & Herbert B. Newton. (2006). Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future. Expert Opinion on Pharmacotherapy. 7(6). 749–765. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Nozza Breakdown of academic impact, for papers by Philipp Karschnia Breakdown of academic impact, for papers by Sonia Tejada Breakdown of academic impact, for papers by Ricardo Díez-Valle Breakdown of academic impact, for papers by Masahide Matsuda Breakdown of academic impact, for papers by Nicholas A. Vitanza Breakdown of academic impact, for papers by Abderrahmane Hamlat Breakdown of academic impact, for papers by Ulf Nestler Breakdown of academic impact, for papers by Ali Chahlavi Breakdown of academic impact, for papers by Jaime Gállego Pérez‐Larraya
Rankless by CCL
2026